NO2982810T3 - - Google Patents

Info

Publication number
NO2982810T3
NO2982810T3 NO15002198A NO15002198A NO2982810T3 NO 2982810 T3 NO2982810 T3 NO 2982810T3 NO 15002198 A NO15002198 A NO 15002198A NO 15002198 A NO15002198 A NO 15002198A NO 2982810 T3 NO2982810 T3 NO 2982810T3
Authority
NO
Norway
Application number
NO15002198A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2982810T3 publication Critical patent/NO2982810T3/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708—Rheum (rhubarb)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Emergency Medicine (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
NO15002198A 2013-01-25 2015-07-24 NO2982810T3 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361757058P 2013-01-25 2013-01-25

Publications (1)

Publication Number Publication Date
NO2982810T3 true NO2982810T3 (cg-RX-API-DMAC10.html) 2018-08-04

Family

ID=51228097

Family Applications (1)

Application Number Title Priority Date Filing Date
NO15002198A NO2982810T3 (cg-RX-API-DMAC10.html) 2013-01-25 2015-07-24

Country Status (11)

Country Link
US (1) US10195242B2 (cg-RX-API-DMAC10.html)
EP (1) EP2948129B1 (cg-RX-API-DMAC10.html)
JP (1) JP6408489B2 (cg-RX-API-DMAC10.html)
AU (1) AU2014209162B2 (cg-RX-API-DMAC10.html)
CA (1) CA2894240C (cg-RX-API-DMAC10.html)
DK (1) DK2948129T3 (cg-RX-API-DMAC10.html)
ES (1) ES2659066T3 (cg-RX-API-DMAC10.html)
NO (1) NO2982810T3 (cg-RX-API-DMAC10.html)
PL (1) PL2948129T3 (cg-RX-API-DMAC10.html)
PT (1) PT2948129T (cg-RX-API-DMAC10.html)
WO (1) WO2014117056A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106729575A (zh) * 2017-01-25 2017-05-31 深圳市艾梵诗生物技术有限公司 具有青少年抗菌消炎、祛痘淡印功效的中药组合物、美容产品及其制备方法
CA3052047A1 (en) * 2017-02-13 2018-08-16 Wintermute Biomedical, Inc. Anti-pathogenic therapeutic compositions
MX2021003810A (es) * 2018-10-01 2021-07-06 Wintermute Biomedical Inc Composiciones terapeuticas.

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150052A (en) 1971-02-04 1979-04-17 Wilkinson Sword Limited N-substituted paramenthane carboxamides
US5766614A (en) * 1997-03-20 1998-06-16 Yong; Liu Burn treatment compositions containing herbal mix
JPH11269034A (ja) 1998-03-20 1999-10-05 Shiseido Co Ltd ニキビ改善用皮膚外用剤
JP2000281528A (ja) * 1999-03-31 2000-10-10 Ichimaru Pharcos Co Ltd 化粧料組成物
US6841174B2 (en) * 2000-09-20 2005-01-11 Zeyad Technologies Llc Herbal compositions and treatment methods
JP2002114670A (ja) 2000-10-02 2002-04-16 Noevir Co Ltd 抗菌性皮膚外用剤
US7288265B1 (en) * 2000-10-16 2007-10-30 Lectec Corporation Treating viral infection at smallpox vaccination site
GB0221697D0 (en) 2002-09-18 2002-10-30 Unilever Plc Novel compouds and their uses
EP1595936B1 (en) * 2003-01-27 2011-10-19 Vitamin C60 Bioresearch Corporation Composition for external use
CN100582089C (zh) 2003-11-21 2010-01-20 吉万奥丹股份有限公司 N-取代的对-薄荷烷甲酰胺
US20120328544A1 (en) 2003-12-22 2012-12-27 Nevada Naturals, Inc. Dermatological Treatment Methods And Formulations
JP4927718B2 (ja) 2004-06-18 2012-05-09 シムライズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツト・ゲゼルシヤフト ブラックベリー抽出物
US7691418B2 (en) 2004-09-17 2010-04-06 Oystershell Nv Composition for inhibiting or preventing the formation of a biofilm
GB0423652D0 (en) 2004-10-25 2004-11-24 Univ Coventry Kit
BRPI0612448A2 (pt) * 2005-05-09 2010-11-23 Foamix Ltd composição espumosa de sacarìdeo
CN1969984B (zh) 2006-12-07 2010-12-29 刘爱芹 一种治疗皮肤粉刺和过敏的外用药
TWI428140B (zh) * 2007-03-09 2014-03-01 Otsuka Pharma Co Ltd A freeze-dried preparation containing influenza vaccine and a method for producing the same
US8623335B2 (en) 2007-09-10 2014-01-07 Tauna Ann Waddington Scar and rosacea and other skin care treatment composition and method
CN101991726A (zh) * 2009-08-25 2011-03-30 肖华 一种治疗巨细胞病毒的药物组合物及其制备方法
CN103533947A (zh) 2010-12-28 2014-01-22 卡梅迪斯有限公司 用于治疗和预防感染的植物提取物
CN102178842B (zh) 2011-04-27 2013-10-16 李梅华 一种治疗结核病的药物组合物及应用
CA2957790A1 (en) 2014-08-13 2016-02-18 Akeso Biomedical, Inc. Antimicrobial compounds and compositions, and uses thereof

Also Published As

Publication number Publication date
DK2948129T3 (da) 2018-01-29
PT2948129T (pt) 2018-02-12
JP6408489B2 (ja) 2018-10-17
EP2948129B1 (en) 2017-11-22
AU2014209162A1 (en) 2015-06-04
US20150366925A1 (en) 2015-12-24
AU2014209162B2 (en) 2016-03-24
PL2948129T3 (pl) 2018-05-30
EP2948129A4 (en) 2016-08-31
WO2014117056A1 (en) 2014-07-31
EP2948129A1 (en) 2015-12-02
ES2659066T3 (es) 2018-03-13
JP2016510332A (ja) 2016-04-07
CA2894240A1 (en) 2014-07-31
CA2894240C (en) 2019-01-08
US10195242B2 (en) 2019-02-05

Similar Documents

Publication Publication Date Title
AP2016009275A0 (cg-RX-API-DMAC10.html)
BR112015007533A2 (cg-RX-API-DMAC10.html)
BR102016010778A2 (cg-RX-API-DMAC10.html)
BR112016005248A2 (cg-RX-API-DMAC10.html)
BR112014017733A2 (cg-RX-API-DMAC10.html)
BR112014017739A2 (cg-RX-API-DMAC10.html)
BR112014018516A2 (cg-RX-API-DMAC10.html)
BR112014017765A2 (cg-RX-API-DMAC10.html)
BR112014018480A2 (cg-RX-API-DMAC10.html)
BR112014017855A2 (cg-RX-API-DMAC10.html)
BR112014020341A2 (cg-RX-API-DMAC10.html)
BR112014018468A2 (cg-RX-API-DMAC10.html)
BR112016014762A2 (cg-RX-API-DMAC10.html)
BR112014019204A2 (cg-RX-API-DMAC10.html)
BR112014017901A2 (cg-RX-API-DMAC10.html)
BR112014017745A2 (cg-RX-API-DMAC10.html)
BR112014017722A2 (cg-RX-API-DMAC10.html)
BR112016013178A2 (cg-RX-API-DMAC10.html)
BR112014017653A2 (cg-RX-API-DMAC10.html)
BR112014018578A2 (cg-RX-API-DMAC10.html)
BR112016011542A2 (cg-RX-API-DMAC10.html)
BR112016009357A2 (cg-RX-API-DMAC10.html)
BR112014017601A2 (cg-RX-API-DMAC10.html)
BR112015015312A2 (cg-RX-API-DMAC10.html)
BR112014024039A2 (cg-RX-API-DMAC10.html)